These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The concept of dose intensification in the treatment of neoplastic disease. Wandl UB; Niederle N Infection; 1992; 20 Suppl 2():S107-10. PubMed ID: 1493934 [TBL] [Abstract][Full Text] [Related]
4. The promise of retinoids to fight against cancer. Altucci L; Gronemeyer H Nat Rev Cancer; 2001 Dec; 1(3):181-93. PubMed ID: 11902573 [TBL] [Abstract][Full Text] [Related]
5. The biologic basis for the use of retinoids in cancer prevention and treatment. Kurie JM Curr Opin Oncol; 1999 Nov; 11(6):497-502. PubMed ID: 10550014 [TBL] [Abstract][Full Text] [Related]
7. From traditional molecular biology to network oncology. Ziogas DE; Katsios C; Roukos DH Future Oncol; 2011 Feb; 7(2):155-9. PubMed ID: 21345133 [No Abstract] [Full Text] [Related]
8. Cytodifferentiation by retinoids, a novel therapeutic option in oncology: rational combinations with other therapeutic agents. Garattini E; Gianni' M; Terao M Vitam Horm; 2007; 75():301-54. PubMed ID: 17368321 [TBL] [Abstract][Full Text] [Related]
9. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology. Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736 [TBL] [Abstract][Full Text] [Related]
10. Retinoids as preventive and therapeutic anticancer agents (Part II). Lippman SM; Kessler JF; Meyskens FL Cancer Treat Rep; 1987 May; 71(5):493-515. PubMed ID: 3552220 [No Abstract] [Full Text] [Related]
11. Medication overuse in oncology: current trends and future implications for patients and society. Schleicher SM; Bach PB; Matsoukas K; Korenstein D Lancet Oncol; 2018 Apr; 19(4):e200-e208. PubMed ID: 29611528 [TBL] [Abstract][Full Text] [Related]
13. Personalised medicine for cancer: from drug development into clinical practice. Jain KK Expert Opin Pharmacother; 2005 Aug; 6(9):1463-76. PubMed ID: 16086635 [TBL] [Abstract][Full Text] [Related]
14. Retinoids for the future: oncology. DiGiovanna JJ J Am Acad Dermatol; 1992 Dec; 27(6 Pt 2):S34-7. PubMed ID: 1460123 [TBL] [Abstract][Full Text] [Related]
15. Vitamin A derivatives in the prevention and treatment of human cancer. Lippman SM; Meyskens FL J Am Coll Nutr; 1988 Aug; 7(4):269-84. PubMed ID: 3062055 [TBL] [Abstract][Full Text] [Related]
16. [Paediatric oncology in Hungary]. Schuler D Orv Hetil; 2012 May; 153(21):803-10. PubMed ID: 22617369 [TBL] [Abstract][Full Text] [Related]
17. The roles of vitamin A in the prevention of neoplastic diseases: a critical assessment. Cerruti Sola S; Martinetto P; Giovarelli M; Vietti D Boll Ist Sieroter Milan; 1985; 64(1):1-5. PubMed ID: 3890898 [TBL] [Abstract][Full Text] [Related]
18. [Hematopoietic growth factors in oncology and hematology. Recommendations for more cost-efficient use]. Paul C; Hast R Lakartidningen; 2000 Jun; 97(23):2862-6. PubMed ID: 10885223 [No Abstract] [Full Text] [Related]
19. Chemotherapeutic failure: resistance or insensitivity? Braverman AS Ann Intern Med; 1993 Apr; 118(8):630-2. PubMed ID: 8452329 [TBL] [Abstract][Full Text] [Related]